Skip to main content

Table 6 SUCRA ranking of all-cause mortality

From: A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials

Treatment

SUCRA

PrBest

MeanRank

Warfarin

96.6

75.7

1.4

Ambrisentan

82.9

9.4

2.9

N-acetylcysteine

75

11.9

3.8

Bosentan

60.9

0.1

5.3

Macitentan

54.1

2

6

Placebo

51.3

0

6.4

Simtuzumab

48.2

0

6.7

Imatinib

36.4

0.2

8

Pirfenidone

25.6

0

9.2

Nintedanib

24.2

0

9.3

Sildenafil

23.7

0.6

9.4

Pamrevlumab

21.2

0.2

9.7

  1. Higher values of SUCRA indicate higher all-cause mortality
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us